CHF appreciates the opportunity to provide a comment in response to proposed changes to a number of definitions and the scope of the medical device regulatory framework in Australia.
At the heart of CHF’s policy agenda is patient-centred care. Our responses to the TGA’s consultation...
During 2019, the Therapeutic Goods Administration (TGA) will continue to implement changes in response to the Review of Medicines and Medical Devices Regulation (MMDR). This webinar aimed to update consumers on these medical device consultations and answer questions from consumers.
...
This position statement has been developed by the Consumers Health Forum of Australia (CHF) and the Centre for Health Policy, the University of Melbourne. It has been informed by the discussions at a Specialist Fee and Performance Transparency Roundtable held at the University of Melbourne on...
This submission is prepared in the context of an imminent federal election. CHF will be putting out an election priorities document which sets out our proposed agenda for health reform for through to 2025.
CHF's 2017-2018 annual report demonstrates our ongoing commitment to ensuring that integrating the experience and insight of consumers into organisational activities is a priority.
Over thirty years of consumer advocacy in health at the national level is reason to ponder the direction of health care and the role consumers and communities will play in shaping our health care future.
It is common belief that we need more preventative and integrated primary health care...